Annie Umbricht

4.3k total citations · 1 hit paper
53 papers, 3.1k citations indexed

About

Annie Umbricht is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, Annie Umbricht has authored 53 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 25 papers in Public Health, Environmental and Occupational Health and 13 papers in Pharmacology. Recurrent topics in Annie Umbricht's work include Substance Abuse Treatment and Outcomes (25 papers), Opioid Use Disorder Treatment (24 papers) and Prenatal Substance Exposure Effects (8 papers). Annie Umbricht is often cited by papers focused on Substance Abuse Treatment and Outcomes (25 papers), Opioid Use Disorder Treatment (24 papers) and Prenatal Substance Exposure Effects (8 papers). Annie Umbricht collaborates with scholars based in United States and France. Annie Umbricht's co-authors include Kenzie L. Preston, Matthew W. Johnson, Brian D. Richards, William A. Richards, Mary P Cosimano, Roland R. Griffiths, Michael A. Carducci, David H. Epstein, George E. Bigelow and Kenneth Silverman and has published in prestigious journals such as Journal of Consulting and Clinical Psychology, Science Translational Medicine and Neuropsychopharmacology.

In The Last Decade

Annie Umbricht

51 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

2016 1.4k citations Matthew W. Johnson, Annie Umbricht et al. profile →

Peers

Countries citing papers authored by Annie Umbricht

Since Specialization

Citations

This map shows the geographic impact of Annie Umbricht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Umbricht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Umbricht more than expected).

Fields of papers citing papers by Annie Umbricht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Umbricht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Umbricht. The network helps show where Annie Umbricht may publish in the future.

Co-authorship network of co-authors of Annie Umbricht

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Umbricht. A scholar is included among the top collaborators of Annie Umbricht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Umbricht. Annie Umbricht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Brain imaging of cannabinoid type I (CB₁) receptors in women with cannabis use disorder and male and female healthy controls 2021 ·Addiction Biology ·Tory R. Spindle, Hiroto Kuwabara, (unknown), Ayon Nandi, Ryan G. Vandrey, Denis Antoine, Annie Umbricht, Ángela S. Guarda, Dean F. Wong, Elise M. Weerts	28
2	Increases in body mass index and cardiovascular risk factors during methadone maintenance treatment 2019 ·Journal of Opioid Management ·Mary M. Sweeney, Denis Antoine, (unknown), Hélène Geniaux, Michelle R. Lofwall, George E. Bigelow, Annie Umbricht	18
3	The effects of extended-release injectable naltrexone and incentives for opiate abstinence in heroin-dependent adults in a model therapeutic workplace: A randomized trial 2019 ·Drug and Alcohol Dependence ·Brantley P. Jarvis, August F. Holtyn, Anthony DeFulio, Mikhail N. Koffarnus, Jeannie‐Marie Leoutsakos, Annie Umbricht, Michael Fingerhood, George E. Bigelow, Kenneth Silverman	17
4	Factors associated with using opiates while under extended-release naltrexone blockade: A descriptive pilot study 2016 ·Journal of Substance Abuse Treatment ·Brantley P. Jarvis, Anthony DeFulio, (unknown), August F. Holtyn, Annie Umbricht, Michael Fingerhood, George E. Bigelow, Kenneth Silverman	8
5	Employment-based reinforcement of adherence to oral naltrexone in unemployed injection drug users: 12-month outcomes. 2014 ·Psychology of Addictive Behaviors ·Kelly E. Dunn, Anthony DeFulio, (unknown), Wendy D. Donlin, Will M. Aklin, Paul A. Nuzzo, Jeannie‐Marie Leoutsakos, Annie Umbricht, Michael Fingerhood, George E. Bigelow, Kenneth Silverman	17
6	Topiramate impairs cognitive function in methadone-maintained individuals with concurrent cocaine dependence. 2014 ·Psychology of Addictive Behaviors ·Olga Rass, Annie Umbricht, George E. Bigelow, Eric C. Strain, Matthew W. Johnson, Miriam Z. Mintzer	4
7	Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users. 2012 ·Experimental and Clinical Psychopharmacology ·Kelly E. Dunn, Anthony DeFulio, (unknown), Wendy D. Donlin, Will M. Aklin, Paul A. Nuzzo, Jeannie‐Marie Leoutsakos, Annie Umbricht, Michael Fingerhood, George E. Bigelow, Kenneth Silverman	39
8	Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans 2012 ·Drug and Alcohol Dependence ·Marilyn A. Huestis, Edward J. Cone, Stéphane Pirnay, Annie Umbricht, Kenzie L. Preston	40
9	Employment‐based reinforcement of adherence to depot naltrexone in unemployed opioid‐dependent adults: a randomized controlled trial 2011 ·Addiction ·(unknown), Anthony DeFulio, Mikhail N. Koffarnus, Jeannie‐Marie Leoutsakos, Wendy D. Donlin, Will M. Aklin, Annie Umbricht, Michael Fingerhood, George E. Bigelow, Kenneth Silverman	50
10	Increased Blood Pressure After Abrupt Cessation of Daily Cannabis Use 2010 ·Journal of Addiction Medicine ·Ryan G. Vandrey, Annie Umbricht, Eric C. Strain	32
11	Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency 2008 ·Drug and Alcohol Dependence ·David H. Epstein, John Schmittner, Annie Umbricht, Jennifer R. Schroeder, Eric T. Moolchan, Kenzie L. Preston	47
12	Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence 2005 ·Addictive Behaviors ·Jennifer R. Schroeder, David H. Epstein, Annie Umbricht, Kenzie L. Preston	45
13	Gender Differences in Indices of Opioid Dependency and Medical Comorbidity in a Population of Hospitalized HIV‐Infected African‐Americans 2004 ·American Journal on Addictions ·Susan J. Boyd, (unknown), Annie Umbricht, M TUCKER, (unknown), Richard E. Chaisson, Kenzie L. Preston	2
14	Cyclazocine: comparison to hydromorphone and interaction with cocaine 2004 ·Behavioural Pharmacology ·Kenzie L. Preston, Annie Umbricht, Jennifer Schroeder, M E Abreu, David H. Epstein, Wallace B. Pickworth	14
15	Do noncontingent vouchers increase drug use? 2003 ·Experimental and Clinical Psychopharmacology ·Jennifer R. Schroeder, (unknown), David H. Epstein, Annie Umbricht, Kenzie L. Preston	5
16	Cognitive-behavioral therapy plus contingency management for cocaine use: Findings during treatment and across 12-month follow-up. 2003 ·Psychology of Addictive Behaviors ·David H. Epstein, Wesley E. Hawkins, Lino Covi, Annie Umbricht, Kenzie L. Preston	118
17	Abstinence reinforcement maintenance contingency and one-year follow-up 2002 ·Drug and Alcohol Dependence ·Kenzie L. Preston, Annie Umbricht, David H. Epstein	45
18	Shaping cocaine abstinence by successive approximation. 2001 ·Journal of Consulting and Clinical Psychology ·Kenzie L. Preston, Annie Umbricht, Conrad J. Wong, (unknown)	16
19	Improvement in naltrexone treatment compliance with contingency management 1999 ·Drug and Alcohol Dependence ·Kenzie L. Preston, Kenneth Silverman, Annie Umbricht, (unknown), Iván D. Montoya, Charles R. Schuster	141
20	Monitoring Cocaine Use in Substance-Abuse-Treatment Patients by Sweat and Urine Testing 1999 ·Journal of Analytical Toxicology ·Kenzie L. Preston, Marilyn A. Huestis, Conrad J. Wong, Annie Umbricht, Bruce A. Goldberger, Edward J. Cone	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact